טוען...
Two-Stage Adaptive Designs for Three-Treatment Bioequivalence Studies
Bioequivalence (BE) studies are most often conducted as crossover trials, and therefore establishing their required sample size necessitates specification of the within-person variance. Given that this specification is often difficult in practice, there has been great interest in recent years in the...
שמור ב:
| הוצא לאור ב: | Stat Biopharm Res |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7612189/ https://ncbi.nlm.nih.gov/pubmed/35003526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19466315.2019.1654911 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|